ORBIMED ADVISORS LLC – Sarepta Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$101.53M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+47.47%
quarter
Sarepta Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4492.50% | 898.5K shares | 100.03M | $110.54 | 918.5K |
| Q2 2022 | share | Decrease | -48.85% | -19.1K shares | -1.55M | $74.96 | 20K |
| Q1 2022 | share | Decrease | -33.39% | -19.6K shares | -2.23M | $78.12 | 39.1K |
| Q4 2021 | share | Decrease | -9.27% | -6K shares | -697K | $90.59 | 58.7K |
| Q3 2021 | share | 0.00% | 0 shares | 953K | $92.48 | 64.7K | |
| Q2 2021 | share | Decrease | -67.69% | -135.57K shares | -9.89M | $77.74 | 64.7K |
| Q1 2021 | share | Decrease | -62.85% | -338.77K shares | -76.97M | $74.53 | 200.27K |
| Q1 2021 | call | Decrease | -100.00% | -50K shares | -8.52M | $74.53 | 0 |
| Q4 2020 | share | 0.00% | 0 shares | 16.20M | $170.49 | 539.04K | |
| Q4 2020 | call | Increase | 0.00% | 50K shares | 8.52M | $170.49 | 50K |
| Q3 2020 | share | Decrease | -3.68% | -20.6K shares | -14.03M | $140.43 | 539.04K |
| Q2 2020 | share | Decrease | -37.99% | -342.8K shares | 1.45M | $160.34 | 559.64K |
| Q1 2020 | share | Increase | +17.81% | 136.4K shares | -10.57M | $97.82 | 902.44K |
| Q4 2019 | call | Decrease | -100.00% | -50K shares | -3.76M | $129.04 | 0 |
| Q4 2019 | share | Decrease | -8.51% | -71.3K shares | 35.78M | $129.04 | 766.04K |
| Q3 2019 | share | Increase | +1.08% | 8.94K shares | -62.80M | $75.32 | 837.34K |
| Q3 2019 | call | Increase | 0.00% | 50K shares | 3.76M | $75.32 | 50K |
| Q2 2019 | share | 0.00% | 0 shares | 27.13M | $151.95 | 828.4K | |
| Q1 2019 | share | Increase | +6.07% | 47.4K shares | 13.50M | $119.19 | 828.4K |
| Q4 2018 | share | Decrease | -8.59% | -73.4K shares | -52.76M | $109.13 | 781K |
| Q3 2018 | share | Increase | +88.78% | 401.8K shares | 78.16M | $161.51 | 854.4K |
| Q2 2018 | share | Increase | +40.73% | 131K shares | 35.99M | $132.18 | 452.6K |
| Q2 2018 | call | Decrease | -100.00% | -50K shares | -3.70M | $132.18 | 0 |
| Q1 2018 | call | 0.00% | 0 shares | 923K | $74.09 | 50K | |
| Q1 2018 | share | Increase | +223.54% | 222.2K shares | 18.29M | $74.09 | 321.6K |
| Q4 2017 | share | Increase | 0.00% | 99.4K shares | 5.53M | $55.64 | 99.4K |
| Q4 2017 | call | Decrease | -66.67% | -100K shares | -4.02M | $55.64 | 50K |
| Q3 2017 | call | Increase | 0.00% | 150K shares | 6.80M | $45.36 | 150K |
| Q2 2017 | share | Decrease | -100.00% | -1.05M shares | -31.20M | $33.71 | 0 |
| Q1 2017 | share | Increase | 0.00% | 1.05M shares | 31.20M | $29.6 | 1.05M |
| Q4 2016 | share | Decrease | -100.00% | -261.8K shares | -16.07M | $27.43 | 0 |
| Q3 2016 | share | Increase | 0.00% | 261.8K shares | 16.07M | $61.41 | 261.8K |